Tomas Leanderson
Corporate Officer/Principal bei University of Lund
Profil
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB.
Leanderson earned a doctorate degree from Umea Universitet.
Aktive Positionen von Tomas Leanderson
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 06.05.2010 |
Ehemalige bekannte Positionen von Tomas Leanderson
| Unternehmen | Position | Ende |
|---|---|---|
| ACTIVE BIOTECH AB | Vorstandsvorsitzender | 01.07.2017 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | - |
Ausbildung von Tomas Leanderson
| Umea Universitet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
